Can China’s ‘standard of care’ for COVID-19 be replicated in Europe?

Author:

Raposo Vera LuciaORCID

Abstract

The Director-General of the WHO has suggested that China’s approach to the COVID-19 crisis could be the standard of care for global epidemics. However, as remarkable as the Chinese strategy might be, it cannot be replicated in other countries and certainly not in Europe. In Europe, there is a distribution of power between the European Union and its member states. In contrast, China’s political power is concentrated in the central government. This enables it to take immediate measures that affect the entire country, such as massive quarantines or closing borders. Moreover, the Chinese legal framework includes restrictions on privacy and other human rights that are unknown in Europe. In addition, China has the technological power to easily impose such restrictions. In most European countries, that would be science fiction. These conditions have enabled China to combat epidemics like no other country can. However, the WHO might have been overoptimistic. The Chinese standard of care for treating COVID-19 also raises problematic issues for human rights, and the real consequences of these actions remain to be seen.

Funder

Universidade de Macau

Publisher

BMJ

Subject

Health Policy,Arts and Humanities (miscellaneous),Issues, ethics and legal aspects,Health (social science)

Reference25 articles.

1. Who Director-General's statement on IHR emergency Committee on novel coronavirus (2019-nCoV), 2020. Available: https://www.who.int/dg/speeches/detail/who-director-general-s-statement-on-ihr-emergency-committee-on-novel-coronavirus-(2019-ncov) [Accessed 8 Feb 2020].

2. Kickbusch I , Leung G . Response to the emerging novel coronavirus outbreak, worldwide political commitment to pandemic preparedness is essential. BMJ 2020;368:m406.

3. Politico, how Europe is responding to the coronavirus pandemic, Politico, 3/13/20, 2020. Available: https://www.politico.eu/article/how-europe-is-responding-to-the-coronavirus-pandemic/ [Accessed 26 Apr 2020].

4. Qu T , Zhang J . How China has turned to Tech like never before to combat the coronavirus. South China Morning Post 2020. https://www.scmp.com/tech/apps-social/article/3051587/how-china-has-turned-tech-never-combat-coronavirus

5. Machine learning and Enculturation: perspective of international human rights in China;IOSR Journal of Engineering,2019

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3